Effectiveness of oral mucositis (OM) pain control with the current standard of care management were assessed using clinician and self-reported scales in haematopoietic stem cell transplant (HSCT) patients. A prospective observational study was performed using clinician-assessed (World Health Organization-WHO) Oral Toxicity Scales and self-reported scales (Oral Mucositis Daily Questionnaires-OMDQ). A total of 23 HSCT patients were included in the study. There were 100-recorded-days of OM using WHO scores, and 144-recorded-days of OM using OMDQ. A total of 14/23 (60.9%) patients experienced mucositis. The presence of OM was significantly associated with increase in actual body weight (t(21)=2.15, p=0.044), body surface area (t(21)=2.31, p=0.031) and body mass index (t(21)=2.13, p=0.044), longer hospital stays (t(21)=2.45, p=0.023) and busulphan-based regimens (=4.32, p=0.038). The degree of pain relief was significantly inversely correlated to both the degree of WHO graded OM severity (ρ=-0.586; p
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
